Hypoxia associated biomarkers in HER2+ breast cancer cell lines for personalized therapy

Project Details


The aim of the project is to identify potential acute hypoxia-related biomarkers and therapy targets by conducting large-scale bioinformatics data analysis in the publicly available Metabric database of breast cancer multi-omics files and to verify them experimentally in HER2+ breast cancer reference cell lines.
Effective start/end date1/07/2030/06/21


  • Riga Stradins University: €20,000.00


  • hypoxia
  • breast cancer
  • HER2
  • biomarkers
  • oncology

Field of Science

  • 3.1 Basic medicine

Smart Specialization Area

  • Biomedicine, medical technologies and biotechnology


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.